# AFINITOR DISPERZ
> **NDA203985** · New Drug Application · Sponsor: NOVARTIS PHARM · Approved 2012-08-29
## Drug
- **FDA Application Number:** NDA203985
- **Application type:** New Drug Application
- **Brand name:** AFINITOR DISPERZ
- **Generic name:** EVEROLIMUS
- **Active ingredients:** EVEROLIMUS
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS PHARM
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2012-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203985)
---
*AI Analytics · CC0 1.0*